Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future
- PMID: 14610170
- PMCID: PMC262597
- DOI: 10.1128/jvi.77.23.12460-12465.2003
Retrospective analysis of a local cessation of vaccination against poliomyelitis: a possible scenario for the future
Abstract
The global eradication of poliomyelitis will require substantial changes in immunization practices. One of the proposed scenarios includes cessation of vaccination with live oral poliovirus vaccine (OPV) and the creation of an OPV stockpile for emergency response in case of the reintroduction of poliovirus into circulation. We describe here a retrospective analysis of the cessation of OPV usage in a region of the Byelorussian Republic of the former Soviet Union in 1963 to 1966. During this period, a widespread circulation and evolution of independent lineages of vaccine-derived polioviruses took place in the region. Some of these lineages appeared to originate from OPV given to 40 children in the community during this period of essentially no vaccinations. The data demonstrate very high risks associated with both the local cessation of OPV vaccination and the proposed use of OPV to control a possible reemergence of poliovirus in the postvaccination period. The high transmissibility of OPV-derived viruses in nonimmune population, documented here, and the known existence of long-term OPV excretors should be also considered in assessing risks of the synchronized global cessation of OPV usage.
Figures


Similar articles
-
Characterization of outbreak response strategies and potential vaccine stockpile needs for the polio endgame.BMC Infect Dis. 2016 Mar 24;16:137. doi: 10.1186/s12879-016-1465-7. BMC Infect Dis. 2016. PMID: 27009272 Free PMC article.
-
Transmissibility and persistence of oral polio vaccine viruses: implications for the global poliomyelitis eradication initiative.Am J Epidemiol. 1999 Nov 15;150(10):1001-21. doi: 10.1093/oxfordjournals.aje.a009924. Am J Epidemiol. 1999. PMID: 10568615 Review.
-
Modeling the dynamics of oral poliovirus vaccine cessation.J Infect Dis. 2014 Nov 1;210 Suppl 1:S475-84. doi: 10.1093/infdis/jit845. J Infect Dis. 2014. PMID: 25316870
-
Molecular evolution of oral poliovirus vaccine strains during multiplication in humans and possible implications for global eradication of poliovirus.Acta Virol. 2000 Apr;44(2):109-17. Acta Virol. 2000. PMID: 10989702 Review.
-
An economic analysis of poliovirus risk management policy options for 2013-2052.BMC Infect Dis. 2015 Sep 24;15:389. doi: 10.1186/s12879-015-1112-8. BMC Infect Dis. 2015. PMID: 26404632 Free PMC article.
Cited by
-
Multiplex PCR method for identifying recombinant vaccine-related polioviruses.J Clin Microbiol. 2004 Sep;42(9):4313-5. doi: 10.1128/JCM.42.9.4313-4315.2004. J Clin Microbiol. 2004. PMID: 15365031 Free PMC article.
-
Long-term excretion of vaccine-derived poliovirus by a healthy child.J Virol. 2004 Dec;78(24):13839-47. doi: 10.1128/JVI.78.24.13839-13847.2004. J Virol. 2004. PMID: 15564492 Free PMC article.
-
Evolution of the Sabin vaccine into pathogenic derivatives without appreciable changes in antigenic properties: need for improvement of current poliovirus surveillance.J Virol. 2009 Apr;83(7):3402-6. doi: 10.1128/JVI.02122-08. Epub 2009 Jan 7. J Virol. 2009. PMID: 19129444 Free PMC article.
-
Robustness against serum neutralization of a poliovirus type 1 from a lethal epidemic of poliomyelitis in the Republic of Congo in 2010.Proc Natl Acad Sci U S A. 2014 Sep 2;111(35):12889-94. doi: 10.1073/pnas.1323502111. Epub 2014 Aug 18. Proc Natl Acad Sci U S A. 2014. PMID: 25136105 Free PMC article.
-
Paralysis case and contact spread of recombinant vaccine-derived poliovirus, Spain.Emerg Infect Dis. 2008 Nov;14(11):1807-9. doi: 10.3201/eid1411.080517. Emerg Infect Dis. 2008. PMID: 18976579 Free PMC article. No abstract available.
References
-
- Bellmunt, A., G. May, R. Zell, P. Pring-Akerblom, W. Verhagen, and A. Heim. 1999. Evolution of poliovirus type I during 5.5 years of prolonged enteral replication in an immunodeficient patient. Virology 265:178-184. - PubMed
-
- Butinelli, G., V. Donati, S. Fiore, J. Marturano, A. Plebani, P. Balestri, A. R. Soresina, R. Vivarelli, F. Delpeyroux, J. Martin, and L. Fiore. 2003. Nucleotide variation in Sabin type 2 poliovirus from an immunodeficient patient with poliomyelitis. J. Gen. Virol. 84:1215-1221. - PubMed
-
- Centers for Disease Control and Prevention. 1997. Paralytic poliomyelitis-United States, 1980-1994. Morb. Mortal. Wkly. Rep. 46:79-83. - PubMed
-
- Centers for Disease Control and Prevention. 2001. Public health dispatch: acute flaccid paralysis associated with circulating vaccine-derived poliovirus-Philippines, 2001. Morb. Mortal. Wkly. Rep. 50:874-875. - PubMed
-
- Centers for Disease Control and Prevention. 2001. Circulation of a type 2 vaccine-derived poliovirus-Egypt, 1982-1993. Morb. Mortal. Wkly. Rep. 50:41-51. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources